2Dugo L,Collin M,Thiemermann C.Glycogen synthase kinase 3beta as a target for the therapy of shock and inflammation[J].Shock,2007,27(2):113-123.
3Woodgett JR,Ohashi PS.GSK3:an in-Toll-erant protein kinase?[J].Nat Immunol,2005,6(8):751-752.
4Miyawaki T,Ofengeim D,Noh KM,et al.The endogenous inhibitor of Akt,CTMP,is critical to ischemia-induced neuronal death[J].Nat Neurosci,2009,12(5):618-626.
5Hotokezaka Y,van Leyen K,Lo EH,et al.alphaNAC depletion as an initiator of ER stress-induced apoptosis in hypoxia[J].Cell Death Differ,2009,16(11):1505-1514.
6Chong ZZ,Li F,Maiese K.Activating Akt and the brain's resources to drive cellular survival and prevent inflammatory injury[J].Histol Histopathol,2005,20(1):299-315.
7Shioda N,Han F,Fukunaga K.Role of Akt and ERK signaling in the neurogenesis following brain ischemia[J].Int Rev Neurobiol,2009,85:375-387.
8Zhao H,Shimohata T,Wang JQ,et al.Akt contributes to neuroprotection by hypothermia against cerebral ischemia in rats[J].J Neurosci,2005,25(42):9794-9806.
9Sasaki C,Hayashi T,Zhang WR,et al.Different expression of glycogen synthase kinase-3beta between young and old rat brains after transient middle cerebral artery occlusion[J].Neurol Res,2001,23(6):588-592.
10Endo H,Nito C,Kamada H,et al.Activation of the Akt/GSK3beta signaling pathway mediates survival of vulnerable hippocampal neurons after transient global cerebral ischemia in rats[J].J Cereb Blood Flow Metab,2006,26(12):1479-1489.
